TY - JOUR
T1 - Niemann-Pick disease type C clinical database
T2 - Cognitive and coordination deficits are early disease indicators
AU - Stampfer, Miriam
AU - Theiss, Susanne
AU - Amraoui, Yasmina
AU - Jiang, Xuntian
AU - Keller, Sigrid
AU - Ory, Daniel S.
AU - Mengel, Eugen
AU - Fischer, Christine
AU - Runz, Heiko
N1 - Funding Information:
We are grateful to the patients and their families for their support and willingness to participate in this study. This work was supported by unrestricted research grants from Actelion Pharmaceuticals Deutschland GmbH and the Ara Parseghian Medical Research Foundation (APMRF).
PY - 2013
Y1 - 2013
N2 - Background: The neurodegenerative lysosomal storage disorder Niemann-Pick disease type C (NP-C) is characterized by a broad clinical variability involving neurological, psychiatric and systemic signs. Diverse patterns of disease manifestation and progression considerably delay its diagnosis. Here we introduce the NP-C clinical database (NPC-cdb) to systematically obtain, store and analyze diagnostic and clinical findings in patients with NP-C. We apply NPC-cdb to study NP-C temporal expression in a large German-Swiss patient cohort. Methods. Current and past medical history was systematically acquired from 42 patients using tailored questionnaires. Manifestation of 72 distinct neuropsychiatric signs was modeled over the course of disease. The sequence of disease progression was re-constructed by a novel clinical outcome scale (NPC-cdb score). Results: The efficiency of current clinical diagnostic standards negatively correlates with duration of disease (p<3. 9x10§ssup§-4§esup§), suggesting insufficient sensitivity in patients early in the disease process. Neurological signs considered as typical for NP-C were frequent (e.g., cognitive impairment 86%, ataxia 79%, vertical supranuclear gaze palsy 76%) and their presence co-occurred with accelerated diagnosis. However, less specific neuropsychiatric signs were reported to arise considerably more early in the disease process (e.g., clumsiness -4.9±1.1 y before diagnosis). Most patients showed a steady disease progression that correlated with age at neurological onset. However, a distinct subcohort (n=6) with initially steadily progressing disease later showed a 2.9-fold accelerated progression that was associated with the onset of seizures (p<7x10§ ssup§-4§esup§), suggesting seizures as predictive for a poor prognosis. Conclusions: Considering early, but less specific neuropsychiatric signs may accelerate the path to diagnosing NP-C in a patient.
AB - Background: The neurodegenerative lysosomal storage disorder Niemann-Pick disease type C (NP-C) is characterized by a broad clinical variability involving neurological, psychiatric and systemic signs. Diverse patterns of disease manifestation and progression considerably delay its diagnosis. Here we introduce the NP-C clinical database (NPC-cdb) to systematically obtain, store and analyze diagnostic and clinical findings in patients with NP-C. We apply NPC-cdb to study NP-C temporal expression in a large German-Swiss patient cohort. Methods. Current and past medical history was systematically acquired from 42 patients using tailored questionnaires. Manifestation of 72 distinct neuropsychiatric signs was modeled over the course of disease. The sequence of disease progression was re-constructed by a novel clinical outcome scale (NPC-cdb score). Results: The efficiency of current clinical diagnostic standards negatively correlates with duration of disease (p<3. 9x10§ssup§-4§esup§), suggesting insufficient sensitivity in patients early in the disease process. Neurological signs considered as typical for NP-C were frequent (e.g., cognitive impairment 86%, ataxia 79%, vertical supranuclear gaze palsy 76%) and their presence co-occurred with accelerated diagnosis. However, less specific neuropsychiatric signs were reported to arise considerably more early in the disease process (e.g., clumsiness -4.9±1.1 y before diagnosis). Most patients showed a steady disease progression that correlated with age at neurological onset. However, a distinct subcohort (n=6) with initially steadily progressing disease later showed a 2.9-fold accelerated progression that was associated with the onset of seizures (p<7x10§ ssup§-4§esup§), suggesting seizures as predictive for a poor prognosis. Conclusions: Considering early, but less specific neuropsychiatric signs may accelerate the path to diagnosing NP-C in a patient.
KW - Cholesterol
KW - Clinical repository
KW - Genotype-phenotype
KW - Neurodegenerative disease
KW - Oxysterols
UR - https://www.scopus.com/pages/publications/84874080589
U2 - 10.1186/1750-1172-8-35
DO - 10.1186/1750-1172-8-35
M3 - Article
C2 - 23433426
AN - SCOPUS:84874080589
SN - 1750-1172
VL - 8
JO - Orphanet Journal of Rare Diseases
JF - Orphanet Journal of Rare Diseases
IS - 1
M1 - 35
ER -